Patrick James Orme

Array ( [id] => 4442343 [patent_doc_number] => 07928083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'H19 silencing nucleic acid agents for treating rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 12/523288 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15138 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928083.pdf [firstpage_image] =>[orig_patent_app_number] => 12523288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825669 [patent_doc_number] => 20080124737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'MicroRNA1 Therapies' [patent_app_type] => utility [patent_app_number] => 12/014761 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2266 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124737.pdf [firstpage_image] =>[orig_patent_app_number] => 12014761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082053 [patent_doc_number] => 08148342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases' [patent_app_type] => utility [patent_app_number] => 12/008578 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 14072 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148342.pdf [firstpage_image] =>[orig_patent_app_number] => 12008578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712769 [patent_doc_number] => 08093366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Dbait and standalone uses thereof' [patent_app_type] => utility [patent_app_number] => 12/520961 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 9051 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093366.pdf [firstpage_image] =>[orig_patent_app_number] => 12520961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564651 [patent_doc_number] => 20090137504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'MICRORNA TARGET SITE BLOCKING OLIGOS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/962579 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21277 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137504.pdf [firstpage_image] =>[orig_patent_app_number] => 11962579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81804 [patent_doc_number] => 07745418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Compositions and methods for inhibiting viral replication' [patent_app_type] => utility [patent_app_number] => 11/959936 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 11627 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745418.pdf [firstpage_image] =>[orig_patent_app_number] => 11959936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220637 [patent_doc_number] => 20100055732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Cardiac Hypertrophy' [patent_app_type] => utility [patent_app_number] => 12/520516 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11288 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055732.pdf [firstpage_image] =>[orig_patent_app_number] => 12520516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440350 [patent_doc_number] => 20100279408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'POLYMERIC SHORT INTERFERING RNA CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/445814 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13770 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279408.pdf [firstpage_image] =>[orig_patent_app_number] => 12445814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7504076 [patent_doc_number] => 08034921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'IRNA agents targeting CCR5 expressing cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/944227 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 27750 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034921.pdf [firstpage_image] =>[orig_patent_app_number] => 11944227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410666 [patent_doc_number] => 20090124565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'COMPOSITION COMPRISING AT LEAST ONE NUCLEOSIDIC MOIETY AS A THERAPEUTIC AGENT, AND CKC' [patent_app_type] => utility [patent_app_number] => 11/939840 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124565.pdf [firstpage_image] =>[orig_patent_app_number] => 11939840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609818 [patent_doc_number] => 07994306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Methods of treating cancer using siRNA molecules directed against CD24' [patent_app_type] => utility [patent_app_number] => 12/312487 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 9664 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994306.pdf [firstpage_image] =>[orig_patent_app_number] => 12312487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527829 [patent_doc_number] => 08304399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Hedgehog signaling pathway proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/448655 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 36 [patent_no_of_words] => 6929 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12448655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808284 [patent_doc_number] => 20080171862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => utility [patent_app_number] => 11/982325 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6042 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171862.pdf [firstpage_image] =>[orig_patent_app_number] => 11982325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189627 [patent_doc_number] => 08183362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => utility [patent_app_number] => 11/982425 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6129 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183362.pdf [firstpage_image] =>[orig_patent_app_number] => 11982425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762803 [patent_doc_number] => 08114981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => utility [patent_app_number] => 11/982441 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6125 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114981.pdf [firstpage_image] =>[orig_patent_app_number] => 11982441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9483086 [patent_doc_number] => 08729037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => utility [patent_app_number] => 11/982345 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6114 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11982345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7730194 [patent_doc_number] => 08101742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => utility [patent_app_number] => 11/982305 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6135 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101742.pdf [firstpage_image] =>[orig_patent_app_number] => 11982305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739998 [patent_doc_number] => 20080233651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => utility [patent_app_number] => 11/982434 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6038 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233651.pdf [firstpage_image] =>[orig_patent_app_number] => 11982434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944577 [patent_doc_number] => 20080081904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'siRNA targeting carbonic anhydrase 4(CA4)' [patent_app_type] => utility [patent_app_number] => 11/978120 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34196 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081904.pdf [firstpage_image] =>[orig_patent_app_number] => 11978120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867460 [patent_doc_number] => 20080146519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'IL-14alpha RNA inhibitors and antibodies to IL-14alpha for treatment of autoimmune diseases and lymphomas' [patent_app_type] => utility [patent_app_number] => 11/977778 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3408 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146519.pdf [firstpage_image] =>[orig_patent_app_number] => 11977778 [rel_patent_id] =>[rel_patent_doc_number] =>)